Lowers Price Target to $135
https://www.benzinga.com/news/22/09/29091169/svb-leerink-maintains-underperform-on-abbvie-lowers-price-target-to-135
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.